期刊文献+

溃疡性结肠炎患者血小板功能状态和组织因子途径抑制物变化的临床研究 被引量:5

The functional state of platelet and tissue factor pathway inhibitor in the patients with ulcerative colitis
原文传递
导出
摘要 目的 探讨溃疡性结肠炎 (UC)患者血小板功能状态和组织因子途径抑制物 (TFPI)的变化。方法 使用TYXN 91智能血液聚集仪测定 47例UC患者和 3 0例对照组血小板聚集率(PAg) ,同时采用ELISA法检测血清P 选择素 (Ps) ,采用发色底物法测定血浆TFPI含量 ,并对其进行相关性分析。结果 活动期UC患者PAg明显高于缓解期和对照组 (P <0 .0 1) ,活动期和缓解期UC患者Ps和TFPI含量均高于对照组 (P <0 .0 1和P <0 .0 5 ) ,PAg与TFPI呈正相关 (γ =0 .62 3 ,P <0 .0 1) ,Ps与TFPI无明显相关性 (γ =0 .2 3 5 ,P >0 .0 5 )。结论 活动期UC患者体内存在血小板激活 ,在缓解期血小板活化程度仍增高 ;UC患者血浆TFPI含量升高 ,且PAg与TFPI在UC患者的血栓前状态中可能发挥着协同作用。 Objective To study the functional state of platelet and the variation of tissue factor pathway inhibitor (TFPI) in the patients with ulcerative colitis (UC).Methods Platelet aggregability (PAg) was detected by TYXN-91 intelligent blood aggregation and coagulation tester;P-selectin (Ps) was determined with ELISA and TFPI consistency was determined with chromogenic peptide substrate method in 47 patients with UC and 30 healthy controls.Results Increased PAg was detected in active UC compared with inactive UC and healthy controls(P<0.01).The levels of Ps and TFPI in the patients with UC were significant higher than those in the controls(P<0.01 and P<0.05).There was a positive correlation between PAg and TFPI(γ=0.623,P<0.01),but there was not correlation between Ps and TFPI(γ= 0.235, P>0.05).Conclusions Active UC is marked by increased platelet activation.The platelet activity was also increased in inactive UC.TFPI was increased in the patients with UC,PAg and TFPI play synergetic role in the prothrombotic state of the patients with UC.
作者 梁坚 杨勤
出处 《临床内科杂志》 CAS 北大核心 2004年第6期405-406,共2页 Journal of Clinical Internal Medicine
关键词 溃疡性结肠炎 血小板聚集 P-选择素 组织因子途径抑制物 Ulcerative colitis Platelet aggregation P-selectin Tissue factor pathway inhibitor
  • 相关文献

参考文献7

  • 1韩红,夏冰,曾宪昌.炎症性肠病的血栓前状态[J].临床血液学杂志,2003,16(2):91-93. 被引量:16
  • 2欧阳钦,潘国宗,温忠慧,万学红,胡仁伟,林三仁,胡品津.对炎症性肠病诊断治疗规范的建议[J].中华内科杂志,2001,40(2):138-141. 被引量:550
  • 3Suzuki K,SugimuraK,Hasegawa K,et al.Activated platelets in ulcerative colitis enhance the production of reactive oxygen species by polymorphonuclear leukocytes.Scand J Gastroenterol,2001,36(12):1301 -1306.
  • 4Souto JC,Martinez E,Roca M,et al.Prothrombotic state and signs of endothelial lesion in plasma of patients with inflammatory bowel disease.Dig Dis Sci,1995,40 (9):1883-1889.
  • 5赵明,包承鑫.组织因子途径抑制物的研究进展[J].中华血液学杂志,1995,16(9):495-497. 被引量:9
  • 6Palmier MO,Hall LT,reisch CM,et al.Clearance of rTFPI in rabbits.Thromb Haemost,1992,68(1):33-36.
  • 7Nishioka T,Yokota M,Hino M.Tissue factor pathway inhibitor can interact with platelets.J Immunol Methods,2002,266(1-2):181-184.

二级参考文献13

  • 1[1]Shivananda S, Lennard-Jones L, Logan R, et al. Incidence of inflammatory bowel disease across Europe: Is there a difference between north and south? Results of the European collaborative study on inflammatory bowel disease(EC-IBD). Gut, 1996,39: 690 - 697.
  • 2[2]Souto J C, Martin E, Roca M, et al. Prothrombotic state and signs of endothelial lesion in plasma of patients with inflammatory bowel disease. Dig Dis Sci, 1995,40:1883-1889.
  • 3[3]Vrij A A,Rijken J, Wersch J W, et al. Platelet factor 4and beta-thromboglobulin in inflammatory bowel disease and giant cell arteritis. Eur J Clin Invest, 2000,30:188-194.
  • 4[4]Webberley M J, Hart M T, Melikian V, et al. Thromboembolism in inflammatory bowel disease: Role of platelets. Gut,1993,34:247-251.
  • 5[5]Jaremo P. Sandberg-Gertzen H. Platelet density and size in inflammatory bowel disease. Thromb Haemost,1996,75:560-561.
  • 6[6]Weber P, Husemann S, Vielhaber H, et al. Coagulation and fibrinolysis in children, adolescents,and young adults with inflammatory bowel disease. J Pediatr Gastroenterol Nutr, 1999,28:418-422.
  • 7[7]Smith C J, Haire W D, Kaufmann S S, et al. Determination of prothrombin activation fragments in young patients with inflammatory bowel disease. Am J Gastroenterol, 1996,91:1221 - 1225.
  • 8[8]Braham A, Safer L, Bdioui F, et al. Antiphospholipid antibodies in digestive disease. Press Med, 2001,30:1890-1897.
  • 9[9]J unge U, Wienke J, Schuler A. Acute Buddi-Chiari syndrom, portal and splenic vein thrombosis in a patients with ulcerative colitis associate with antiphospholipid antibodies and protein C deficiency. Gastroenterology,2001,39: 845-852.
  • 10[10]Maire F, Beaugerie L, Cohen M, et al. Factors associated with hyperhomocysteinemia in Crohn's disease.Gastroenterol Clin Biol, 2001,25: 745 - 748.

共引文献568

同被引文献88

引证文献5

二级引证文献85

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部